NCT00006152View on ClinicalTrials.gov

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2002

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

DRUG

Abacavir sulfate

DRUG

Amprenavir

Trial Locations (13)

10003

Beth Israel Med Ctr, New York

27710

Duke Univ Med Ctr, Durham

29169

Julio Arroyo, West Columbia

35294

Univ of Alabama at Birmingham, Birmingham

60611

Northwestern Univ Med School, Chicago

60612

The CORE Ctr, Chicago

63112

St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis

80262

Univ of Colorado Health Sciences Ctr, Denver

92103

Univ of California, San Diego, San Diego

275997215

Univ of North Carolina, Chapel Hill

775550435

Univ of Texas Galveston, Galveston

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

02215

Beth Israel Deaconess - West Campus, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00006152 - A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment | Biotech Hunter | Biotech Hunter